Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SasfiledCriticalMerial Sas
Priority to MYPI90001910ApriorityCriticalpatent/MY153646A/en
Publication of MY153646ApublicationCriticalpatent/MY153646A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
THE PROTECTING VACCINE AGAINS PIG HAEMOPHILOSIS INCLUDES THE TOXIN FROM SEROTYPE 1 HEMOPHILUS (ACTINOBACILLUS) PLEUROPNEUMONIAE, WHICH IS THE BASIS FOR THE CYTOTOXIC AND HAEMOLYTIC ACTIVITY OF H. PLEUROPNEUMONIAE, IN A VEHICLE OR EXCIPIENT BELONGING TO THE TYPES USED IN THE PREPARATION OF VACCINES.
MYPI90001910A1990-10-311990-10-31A vaccine protecting against pig haemophilosis.
MY153646A
(en)
Combination of diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, pertactin and capsular polysaccharide of haemophilus influenzae type b (InfanrixHib)
ANTIBIOTICS A42125, PROCEDURES FOR PREPARING THEREOF, NOCARDIA AEROCOLONIGEN'S TRIBLE NRRL 18049 FOR USING THE PROCEDURE AND FEED PREPARATION CONTAINING ANTIBIOTIC
ATTENUATED THUS OBTAINED. PROCEDURE FOR THE PREPARATION OF AN IMPROVED MUTANT STRAIN OF BORDETELLA BRONCHISEPTICA USEFUL FOR A LIVE ATTENUATED VACCINE FOR THE PROTECTION FROM B. BRONCHISEPTICA INFECTIONS AND LIVE AR VACCINE